Lipid-regulating Drugs Market, Global Outlook and Forecast 2022-2028

April 2022 | 66 pages | ID: LBA3CE1CD82BEN
Market Monitor Global

Abstracts

Lipid-regulating drugs are used to treat dyslipidemias, cardiovascular problems, osteoporosis, and post-menopause complications.

This report contains market size and forecasts of Lipid-regulating Drugs in Global, including the following market information:

Global Lipid-regulating Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Lipid-regulating Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Statins Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lipid-regulating Drugs include AbbVie, Amgen, Andrx Corporation, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, Pfizer and Teva. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lipid-regulating Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lipid-regulating Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Lipid-regulating Drugs Market Segment Percentages, by Type, 2021 (%)

• Statins
• Non-statins

Global Lipid-regulating Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Lipid-regulating Drugs Market Segment Percentages, by Application, 2021 (%)

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

Global Lipid-regulating Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Lipid-regulating Drugs Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lipid-regulating Drugs revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Lipid-regulating Drugs revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Amgen
• Andrx Corporation
• AstraZeneca
• Bristol-Myers Squibb
• Merck
• Novartis
• Pfizer
• Teva

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Lipid-regulating Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Lipid-regulating Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIPID-REGULATING DRUGS OVERALL MARKET SIZE

2.1 Global Lipid-regulating Drugs Market Size: 2021 VS 2028
2.2 Global Lipid-regulating Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Lipid-regulating Drugs Players in Global Market
3.2 Top Global Lipid-regulating Drugs Companies Ranked by Revenue
3.3 Global Lipid-regulating Drugs Revenue by Companies
3.4 Top 3 and Top 5 Lipid-regulating Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Lipid-regulating Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Lipid-regulating Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Lipid-regulating Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Lipid-regulating Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Lipid-regulating Drugs Market Size Markets, 2021 & 2028
  4.1.2 Statins
  4.1.3 Non-statins
4.2 By Type - Global Lipid-regulating Drugs Revenue & Forecasts
  4.2.1 By Type - Global Lipid-regulating Drugs Revenue, 2017-2022
  4.2.2 By Type - Global Lipid-regulating Drugs Revenue, 2023-2028
  4.2.3 By Type - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Lipid-regulating Drugs Market Size, 2021 & 2028
  5.1.2 Retail Pharmacies
  5.1.3 Hospital Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Lipid-regulating Drugs Revenue & Forecasts
  5.2.1 By Application - Global Lipid-regulating Drugs Revenue, 2017-2022
  5.2.2 By Application - Global Lipid-regulating Drugs Revenue, 2023-2028
  5.2.3 By Application - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Lipid-regulating Drugs Market Size, 2021 & 2028
6.2 By Region - Global Lipid-regulating Drugs Revenue & Forecasts
  6.2.1 By Region - Global Lipid-regulating Drugs Revenue, 2017-2022
  6.2.2 By Region - Global Lipid-regulating Drugs Revenue, 2023-2028
  6.2.3 By Region - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Lipid-regulating Drugs Revenue, 2017-2028
  6.3.2 US Lipid-regulating Drugs Market Size, 2017-2028
  6.3.3 Canada Lipid-regulating Drugs Market Size, 2017-2028
  6.3.4 Mexico Lipid-regulating Drugs Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Lipid-regulating Drugs Revenue, 2017-2028
  6.4.2 Germany Lipid-regulating Drugs Market Size, 2017-2028
  6.4.3 France Lipid-regulating Drugs Market Size, 2017-2028
  6.4.4 U.K. Lipid-regulating Drugs Market Size, 2017-2028
  6.4.5 Italy Lipid-regulating Drugs Market Size, 2017-2028
  6.4.6 Russia Lipid-regulating Drugs Market Size, 2017-2028
  6.4.7 Nordic Countries Lipid-regulating Drugs Market Size, 2017-2028
  6.4.8 Benelux Lipid-regulating Drugs Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Lipid-regulating Drugs Revenue, 2017-2028
  6.5.2 China Lipid-regulating Drugs Market Size, 2017-2028
  6.5.3 Japan Lipid-regulating Drugs Market Size, 2017-2028
  6.5.4 South Korea Lipid-regulating Drugs Market Size, 2017-2028
  6.5.5 Southeast Asia Lipid-regulating Drugs Market Size, 2017-2028
  6.5.6 India Lipid-regulating Drugs Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Lipid-regulating Drugs Revenue, 2017-2028
  6.6.2 Brazil Lipid-regulating Drugs Market Size, 2017-2028
  6.6.3 Argentina Lipid-regulating Drugs Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Lipid-regulating Drugs Revenue, 2017-2028
  6.7.2 Turkey Lipid-regulating Drugs Market Size, 2017-2028
  6.7.3 Israel Lipid-regulating Drugs Market Size, 2017-2028
  6.7.4 Saudi Arabia Lipid-regulating Drugs Market Size, 2017-2028
  6.7.5 UAE Lipid-regulating Drugs Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Lipid-regulating Drugs Major Product Offerings
  7.1.4 AbbVie Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Lipid-regulating Drugs Major Product Offerings
  7.2.4 Amgen Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Andrx Corporation
  7.3.1 Andrx Corporation Corporate Summary
  7.3.2 Andrx Corporation Business Overview
  7.3.3 Andrx Corporation Lipid-regulating Drugs Major Product Offerings
  7.3.4 Andrx Corporation Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.3.5 Andrx Corporation Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Lipid-regulating Drugs Major Product Offerings
  7.4.4 AstraZeneca Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Bristol-Myers Squibb
  7.5.1 Bristol-Myers Squibb Corporate Summary
  7.5.2 Bristol-Myers Squibb Business Overview
  7.5.3 Bristol-Myers Squibb Lipid-regulating Drugs Major Product Offerings
  7.5.4 Bristol-Myers Squibb Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.5.5 Bristol-Myers Squibb Key News
7.6 Merck
  7.6.1 Merck Corporate Summary
  7.6.2 Merck Business Overview
  7.6.3 Merck Lipid-regulating Drugs Major Product Offerings
  7.6.4 Merck Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.6.5 Merck Key News
7.7 Novartis
  7.7.1 Novartis Corporate Summary
  7.7.2 Novartis Business Overview
  7.7.3 Novartis Lipid-regulating Drugs Major Product Offerings
  7.7.4 Novartis Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.7.5 Novartis Key News
7.8 Pfizer
  7.8.1 Pfizer Corporate Summary
  7.8.2 Pfizer Business Overview
  7.8.3 Pfizer Lipid-regulating Drugs Major Product Offerings
  7.8.4 Pfizer Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.8.5 Pfizer Key News
7.9 Teva
  7.9.1 Teva Corporate Summary
  7.9.2 Teva Business Overview
  7.9.3 Teva Lipid-regulating Drugs Major Product Offerings
  7.9.4 Teva Lipid-regulating Drugs Revenue in Global Market (2017-2022)
  7.9.5 Teva Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Lipid-regulating Drugs Market Opportunities & Trends in Global Market
Table 2. Lipid-regulating Drugs Market Drivers in Global Market
Table 3. Lipid-regulating Drugs Market Restraints in Global Market
Table 4. Key Players of Lipid-regulating Drugs in Global Market
Table 5. Top Lipid-regulating Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Lipid-regulating Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Lipid-regulating Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Lipid-regulating Drugs Product Type
Table 9. List of Global Tier 1 Lipid-regulating Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Lipid-regulating Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Lipid-regulating Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Lipid-regulating Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Lipid-regulating Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Lipid-regulating Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Lipid-regulating Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Lipid-regulating Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Lipid-regulating Drugs Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Lipid-regulating Drugs Product Offerings
Table 32. AbbVie Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Lipid-regulating Drugs Product Offerings
Table 35. Amgen Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Andrx Corporation Corporate Summary
Table 37. Andrx Corporation Lipid-regulating Drugs Product Offerings
Table 38. Andrx Corporation Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Lipid-regulating Drugs Product Offerings
Table 41. AstraZeneca Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Bristol-Myers Squibb Corporate Summary
Table 43. Bristol-Myers Squibb Lipid-regulating Drugs Product Offerings
Table 44. Bristol-Myers Squibb Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 45. Merck Corporate Summary
Table 46. Merck Lipid-regulating Drugs Product Offerings
Table 47. Merck Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Lipid-regulating Drugs Product Offerings
Table 50. Novartis Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 51. Pfizer Corporate Summary
Table 52. Pfizer Lipid-regulating Drugs Product Offerings
Table 53. Pfizer Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)
Table 54. Teva Corporate Summary
Table 55. Teva Lipid-regulating Drugs Product Offerings
Table 56. Teva Lipid-regulating Drugs Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Lipid-regulating Drugs Segment by Type in 2021
Figure 2. Lipid-regulating Drugs Segment by Application in 2021
Figure 3. Global Lipid-regulating Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Lipid-regulating Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Lipid-regulating Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Lipid-regulating Drugs Revenue in 2021
Figure 8. By Type - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 12. US Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 24. China Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Lipid-regulating Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Lipid-regulating Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Andrx Corporation Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bristol-Myers Squibb Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Merck Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Pfizer Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Lipid-regulating Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)